MedIngenuity has assisted Promus Diagnostics with brand development from day one. The client chose the word “Promus” because it translates to “stewardship” in Latin — a concept that is a core tenet of their business as a high-tech diagnostic laboratory that focuses on antibiotic stewardship.
During the COVID-19 pandemic, Promus Diagnostics developed a new test called qNAT, a quantitative neutralizing antibody test that detects COVID-19 antibody activity in a patients blood. This information can then be used to determine the effectiveness of the patients vaccine or indicate if they had a prior infection of COVID-19.
MedIngenuity was tasked with creating a qNAT wordmark, which you can see here in a mockup of potential packaging for the qNAT product.